Generalized anxiety disorder: Rethinking diagnosis and rating

CNS Spectrums

Volumn 10, Issue 12, 2005, Pages 930-934

  Stein, Dan J ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; AVOIDANCE BEHAVIOR; BEHAVIOR THERAPY; CASE REPORT; CLINICAL FEATURE; COGNITIVE THERAPY; COMORBIDITY; DIAGNOSTIC PROCEDURE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENERALIZED ANXIETY DISORDER; GENOTYPE ENVIRONMENT INTERACTION; HAMILTON ANXIETY SCALE; HUMAN; PRIORITY JOURNAL; PSYCHOMETRY; RATING SCALE; REVIEW; SYMPTOMATOLOGY;

EID: 29444447626     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900010488     Document Type: Review

References (34)

1. Walker DL, Toufexis DJ, Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol. 2003;463:199-216.
2. Rauch SL, Savage CR, Alpert NM, Fischman AJ, Jenike MA. The functional neuro-anatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry. 1997;42:446-452.
3. Carey PD, Warwick J, Niehaus DJ, et al. Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram. BMC Psychiatry. 2004;4:30.
4. MacLeod AK, Byrne A. Anxiety, depression, and the anticipation of future positive and negative experience. J Abnorm Psychol. 1993;102:238-247.
5. Wu JC, Buchsbaum MS, Hershey TG, Hazlett E, Sicotte N, Johnson JC. PET in generalized anxiety disorder. Biol Psychiatry. 1991;29:1181-1199.
6. De Bellis MD, Casey BJ, Dahl RE, et al. A pilot study of amygdala volumes in pediatric generalized anxiety disorder. Biol Psychiatry. 2000;48:51-57.
7. Mathew SJ, Mao X, Coplan JD, et al. Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: a proton magnetic resonance spectroscopic imaging study. Am J Psychiatry. 2004;161:1119-1121.
8. Stein DJ, Hugo F. Neuropsychiatric aspects of anxiety disorders. In: Yudofsky SC, Hales RE, eds. Tile American Psychiatric Publishing Textbook of Neuropsychiatry and Clinical Neurosciences. Washington, DC: American Psychiatric Publishing; 2002.
9. Ruck C, Andreewitch S, Flyckt K, et al. Capsulotomy for refractory anxiety disorders: long-term follow-up of 26 patients. Am J Psychiatry. 2003;160:513-521.
10. Maron E, Kuikka JT, Ulst K, Tiihonen J, Vasar V, Shlik J. SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder. Eur Arch Psychiatry Clin Neurosci. 2004;254:392-396.
11. Hoehn-Saric R, Schlund MW, Wong SH. Effects of citalopram on worry and brain activation in patients with generalized anxiety disorder. Psychiatry Res. 2005;131:11-21.
12. Tiihonen J, Kuikka J, Rasanen P, et al. Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis. Mol Psychiatry. 1997;2:463-471.
13. Nutt DJ. Neurobiological mechanims in generalized anxiety disorder. J Clin Psychiatry. 2001;62(suppl):22-27.
14. Dalton KM, Kalin NH, Grist TM, Davidson RJ. Neural-cardiac coupling in threat-evoked anxiety. J Cogn Neurosci. 2005;17:969-980.
15. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Major depression and generalized anxiety disorder. Same genes, (partly) different environments? Arch Gen Psychiatry. 1992;49:716-722.
16. Torgersen S. Comorbidity of major depression and anxiety disorders in twin pairs. Am J Psychiatry. 1990;147:1199-1202.
17. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001;158:1568-1578.
18. Munafo MR, Clark T, Flint J. Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits? A meta-analysis. Mol Psychiatry. 2005;10:415-419.
19. Kosel M, Rudolph U, Wielepp P, et al. Diminished GABA(A) receptor-binding capacity and a DNA base substitution in a patient with treatment-resistant depression and anxiety. Neuropsychopharmacology. 2004;29:347-350.
20. Mineka S, Watson D, Clark LA. Comorbidity of anxiety and unipolar mood disorders. Annu Rev Psychol. 1998;49:377-412.
21. Marks IM, Nesse RM. Fears and fitness: an evolutionary analysis of anxiety disorders. Ethol Sociobiol. 1994;15:247-261.
22. Stein DJ, Bouwer C. A neuro-evolutionary approach to the anxiety disorders. J Anxiety Disord. 1997;11:409-429.
23. Ruscio AM, Lane M, Roy-Byme P, et al. Should excessive worry be required for a diagnosis of generalized anxiety disorder? Results from the US National Comorbidity Survey Replication. Psychol Med. 2005;35:1761-1772.
24. Kessler RC, Brandenburg N, Lane M, et al. Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication. Psychol Med. 2005;35:1073-1082.
25. Rickels K, Rynn MA. What is generalized anxiety disorder? J Clin Psychiatry. 2001;62(suppl 11):4-12.
26. Stein D. Tta Cognitive-Affective Neuroscience of Depression and Anxiety Disorders. London, England: Martin Dunitz; 2003.
27. Kapczinski F, Lima MS, Souza JS, Schmitt R. Antidepressants for generalized anxiety disorder. Cochrone Database Syst Rev. 2003;2:CD003592.
28. Gale CK, Oakley-Browne M. Generalized anxiety disorder. Am Farm Physician. 2003;67:135-138.
29. Mitte K, Noack P, Steil R, Hautzinger M. A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder.J Clin Psychopharmacol 2005;25:141-150.
30. Gould RA, Otto MW, Pollack MH, Yap L. Cognitive behavioural and pharmacological management of generalised anxiety disorder a preliminary meta-analysis. Behav Ther. 1997;28:285-305.
31. Ballenger JC, Davidson JR, Lecrubier Y, et al. Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 2001;62:53-58.
32. Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders. World J Biol Psychiatry. 2002;3:171-199.
33. Maier W, Gansicke M, Freyberger HJ, Linz M, Heun R, Lecrubier Y. Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: a valid diagnostic entity? Acta Psychiatr Scand. 2000;101:29-36.
34. Sherboume CD, Wells KB, Meredith LS, Jackson CA, Camp P. Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch Gen Psychiatry. 1996;53:889-895.